Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape. Type 2 diabetes is a chronic condition and is the most common form of diabetes. High levels of glucose are a ... Read More
-
Rubella (German Measles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Rubella (German Measles) (Infectious Disease) pipeline landscape. Rubella also known as the German measles is an acute, contagious viral infection. The rubella virus is transmitted by airborne droplets ... Read More
-
Benign Prostatic Hyperplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Benign Prostatic Hyperplasia (Male Health) pipeline landscape. Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate, a small gland that encircles the urethra in males and ... Read More
-
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Infections - Drugs In Development, 2022, provides an overview of the Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) pipeline landscape. Respiratory syncytial virus (RSV) infection is a respiratory disease. It infects the lungs and breathing ... Read More
-
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Hypercholesterolemia (Metabolic Disorders) pipeline landscape. Hypercholesterolemia is a condition characterized by very high levels of cholesterol in the blood. This leads in formation of sticky deposits (called plaque) along the artery walls. ... Read More
-
Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Diabetes) - Drugs In Development, 2022, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline landscape. Type 1 diabetes (T1D) is an autoimmune disease in which a pancreas stops producing insulin, ... Read More
-
Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Muscular Dystrophy (Musculoskeletal Disorders) pipeline landscape. Muscular dystrophy is a group of diseases in which muscle fibers are unusually susceptible to damage. These damaged muscles become progressively weaker. Symptoms usually ... Read More
-
Pigmented Villonodular Synovitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Pigmented Villonodular Synovitis (Musculoskeletal Disorders) pipeline landscape. Pigmented villonodular synovitis (PVNS) is a condition that causes the synovium. PVNS is characterized by inflammation and overgrowth of the joint ... Read More
-
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Obesity (Metabolic Disorders) pipeline landscape. Obesity is defined as having an excessive amount of body fat. Obesity increases risk of diseases and health problems such as heart disease, diabetes and high blood ... Read More
-
Schizophrenia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... the COVID-19 pandemic had its impact on the schizophrenia market as all the procedures including diagnostic and therapeutic around the world were impacted due to the decline in visits to hospitals and diagnostic centers because ... Read More
-
Sarcopenia Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... by 2027, registering a CAGR of 5.12% from 2022 to 2027. The outbreak of COVID-19 showed an impact on the sarcopenia treatment market because healthcare services were significantly reduced due to social distancing measures taken ... Read More
-
CHINA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... WHO, 20% of persons with diabetes and diabetes-related disorders died in China in January 2020 COVID-19 fatalities. Diabetes affects about one out of every ten COVID-19 patients in China. Diabetes is linked to an increased ... Read More
-
Progressive Multifocal Leukoencephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Progressive Multifocal Leukoencephalopathy (Infectious Disease) pipeline landscape. Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the brain caused by lytic infection of oligodendrocytes by the JC polyomavirus. ... Read More
-
Autism Spectrum Disorder Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031
... is a highly heterogenous disorder characterized by varying social and communication impairments and pervasive repetitive behaviors, in addition to a wide range of associated non-core symptoms. The ASD market is chronically underserved, with no approved ... Read More
-
Celiac Disease
... includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • ... Read More
-
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than 440,000 diagnosed prevalent cases of esophageal cancer across 16 pharmaceutical markets. Currently there are four leading marketed innovator drugs for the treatment of esophageal cancer, mostly programmed cell death protein 1 (PD1) ... Read More
-
RNA Based Therapeutics and Vaccines Market Report 2022-2032
... understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or expand their existing operations in a new region. CRISPR-based RNA Editing to Offer ... Read More
-
Global Growth Hormone Deficiency Market - 2022-2029
... CAGR of 9.4% during the forecast period (2022-2029). Growth hormone deficiency (GHD) is a rare endocrine disorder that occurs due to impaired secretion of somatropin, a peptide growth hormone (GH) from the pituitary gland responsible ... Read More
-
Global Endometriosis Drug Market - 2022-2029
... 10.4% in the forecasted period 2022-2029. Endometriosis is a painful ailment in which tissue analogous to the tissue that usually lines the inside of the uterus (endometrium) grows outside the uterus. Endometriosis most commonly involves ... Read More
-
Global Tumor Necrosis Factor Inhibitor Drugs Market - 2022-2029
... 2029, growing at a CAGR of 16.3% during the forecast period (2022-2029). TNF inhibitors, also called TNF blockers, biologic therapies, or anti-TNF drugs, help stop inflammation. They treat Rheumatoid Arthritis (RA), juvenile arthritis, psoriatic arthritis, ... Read More
-
Global Polyarticular Juvenile Idiopathic Arthritis Drugs Market - 2022-2029
... growth rate (CAGR) of 6.60% over the forecast period 2022 to 2029. Juvenile idiopathic arthritis (JIA) is one of the most common types of arthritis in kids and teens. Juvenile idiopathic arthritis is a chronic ... Read More
-
Global Warts Therapeutics Market - 2022-2029
... during the forecast period (2022-2029). Warts are skin growth that is caused by the human papillomavirus (HPV). It may persist for years and recurs at the same or different sites, even after treatment. Some factors ... Read More
-
Global Bronchiectasis Treatment Market - 2022-2029
... 6.0% during the forecast period (2022-2029). Bronchiectasis is a condition affecting the airways in the lungs that causes cough, increased mucus production, and recurrent lung infections. The symptoms are caused by abnormal widening of the ... Read More
-
Global Chronic Lymphocytic Leukemia Therapeutics Market - 2022-2029
... a CAGR of 7.90% during the forecast period (2022-2029). Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL predominantly affects the B-cell lymphocytes involved in producing ... Read More
-
Global Castrate Resistant Prostate Cancer Therapeutics Market - 2022-2029
... growing at a CAGR of 8.4% during the forecast period (2022-2029). Castration-resistant prostate cancer is stated as prostate cancer that is scattered to other parts of the body. Several risk factors for castration-resistant prostate cancer ... Read More
Research Assistance
